Clinical trial
Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
NCT00002775
Study timeline
Study start (unknown)1998-02-01Date precision: month
Registry last updated2014-01-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
docetaxelDRUG · verified · RxNorm: docetaxel
Sponsors & collaborators
Herbert Irving Comprehensive Cancer Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00002775 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.